Equites Radar

BEP · Brookfield Renewable Partners L

Utilities - RenewableCanadaAnalyst view: Buy

$30.39

-0.39% last session

End-of-day data · close of 2026-09-11

Mildly bearish1 bullish · 3 bearish technical signals
Consensus: Buy (2.24 from 14 analysts)
To mean target: +16.8%

Market cap

$15B

Enterprise value

$82B

Trailing P/E

Forward P/E

-16.3

Dividend yield

5.0%

Beta

0.98

Avg volume

1M

Employees

6K

Daily Change %

-0.39%

5 Days Change

-0.67%

10 Days Change

-1.33%

30 Days Change

-7.71%

60 Days Change

-2.29%

Month to Day Change

-0.22%

Year to Day Change

19.82%

Analyst Outlook

Consensus ratingBuy
Recommendation mean (1–5)2.24
Covering analysts14
Mean price target$35.64
Low price target$20.00
Upside to mean target+16.8%

Analyst estimates change daily — follow the shifts on the Estimate Trends page.

Technical Analysis

RSI (14)37.5
50-day MA$32.24
200-day MA$31.19
Price vs 50-day MA-5.7%
Price vs 200-day MA-2.6%
MACD histogram-0.13
Volume vs 3-month avg1.2×
52w low $24.0852w high $36.63

Analyst sentiment over time — BEP

Rec Mean (blue, left — higher = more bullish) vs. price targets (right).

Investment Bank Ratings as of 2026-07-22

Latest call per bank · past 12 months

Barclays

Equal-Weight

$30.00

-1.7% vs price
▲ raised from $28.00Maintains · 2026-07-22

JP Morgan

Neutral

$36.00

+18.0% vs price
▲ raised from $0.00Downgrade · 2026-07-21

UBS

Buy

$40.00

+31.1% vs price
▲ raised from $39.00Maintains · 2026-06-12

Morgan Stanley

Overweight

$42.00

+37.7% vs price
▲ raised from $38.00Maintains · 2026-03-23

RBC Capital

Outperform

$35.00

+14.7% vs price
▲ raised from $31.00Maintains · 2025-10-30

Recent rating actions

DateFirmActionRatingPrice target
2026-07-22BarclaysMaintainsEqual-Weight$28.00 $30.00
2026-07-21JP MorganDowngradeOverweightNeutral$0.00 $36.00
2026-06-12UBSMaintainsBuy$39.00 $40.00
2026-05-29ScotiabankMaintainsSector Outperform$36.00 $42.00
2026-04-20CIBCMaintainsOutperformer$37.00 $40.00
2026-04-16JP MorganMaintainsOverweight$34.00 $40.00
2026-03-23Morgan StanleyMaintainsOverweight$38.00 $42.00
2026-01-23BarclaysMaintainsEqual-Weight$27.00 $28.00

Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.

Signal Summary as of 2026-09-11

  • RSI (14): RSI is 37 — neutral momentum, neither overbought nor oversold.
  • Price vs 50-day MA: Trading 5.7% below the 50-day MA ($32.24).
  • Price vs 200-day MA: Trading 2.6% below the 200-day MA ($31.19).
  • MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
  • MACD (12,26,9): MACD histogram is negative (-0.13) — short-term momentum is fading.
  • 52-week range: Price sits between the 52-week low ($24.08) and high ($36.63).

BEP Price Chart

Loading chart for BEP

Fundamentals

Revenue (TTM)$6.0B
EBITDA$3.0B
Free cash flow-$12B
Operating cash flow$1.0B
Book value / share$12.46
Net Debt / EBITDA11.7
WACC7.0%
Revenue growth1.00%
Earnings growth

About Brookfield Renewable Partners L

Brookfield Renewable Partners L.P. owns a portfolio of renewable power generating facilities in the North America, Colombia, and Brazil. The company generates electricity through hydroelectric, wind, solar, distributed generation, and pumped storage; and offers sustainable solutions, such as renewable natural gas, carbon capture and storage, recycling, cogeneration, biomass, nuclear services, eFuels, and power transformation. It operates as the general partner of Brookfield Renewable Partners L.P. The company was formerly known as Brookfield Renewable Energy Partners L.P. and changed its name to Brookfield Renewable Partners L.P. in May 2016. The company was founded in 1999 and is based in Toronto, Canada.

More in Utilities - Renewable

Screen BEP against the full market on the Radar →

Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.